The Proportion of Women Who Have a Breast 4 Years after Breast Cancer Surgery: A Population-Based Cohort Study. by Mennie, Joanna C et al.
RESEARCH ARTICLE
The Proportion of Women Who Have a
Breast 4 Years after Breast Cancer Surgery: A
Population-Based Cohort Study
Joanna C. Mennie1,2, Pari-Naz Mohanna2, Joseph M O’Donoghue3, Richard Rainsbury4,
David A. Cromwell1,5*
1 Clinical Effectiveness Unit, Royal College of Surgeons of England, London, United Kingdom,
2 Department of Plastic and Reconstructive Surgery, St Thomas Hospital, Guy’s and St Thomas’ NHS
Foundation Trust, London, United Kingdom, 3 Department of Plastic and Reconstructive Surgery, Royal
Victoria Infirmary, Newcastle Upon Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom,
4 Department of Breast Surgery, Royal Hampshire County Hospital, Hampshire Hospitals NHS Foundation
Trust, Winchester, United Kingdom, 5 Department of Health Services Research & Policy, London School of
Hygiene & Tropical Medicine, London, United Kingdom
* dcromwell@rcseng.ac.uk
Abstract
Background
There are numerous pathways in breast cancer treatment, many of which enable women to
retain a breast after treatment. We evaluated the proportion of women who have a breast,
either through conserving surgery (BCS) or reconstruction, at 4-years after diagnosis, and
how this varied by patient group.
Methods and Findings
We identified women with breast cancer who underwent initial BCS or mastectomy in
English National Health Service (NHS) hospitals between January 2008 and December
2009 using the Hospital Episode Statistics (HES) database. Women were assigned into
one of four patient groups depending on their age at diagnosis and presence of comorbidi-
ties. The series of breast cancer procedure (BCS, mastectomy, immediate, or delayed
reconstruction) undergone by each women was identified over four years, and the propor-
tion of women with a breast calculated. Variation was examined across patient groups, and
English Cancer Networks. Between 2008 and 2009, 60,959 women underwent BCS or
mastectomy. The proportion with a breast at 4 years was 79.3%, and 64.0%, in women less
than 70 years without, and with comorbidities. Whilst in women aged 70 and over without,
and with comorbidities, proportions were 52.6%, and 38.2%, respectively. Comorbidities
were associated with lower proportions of BCS, but had little effect on reconstruction rates
unlike age. Networks variation of 15% or more was found within each patient group, and
Cancer Networks tended to have either a high or low proportion across all four patient
groups. However, while 14% of women under 70 years had undergone reconstruction, less
than 2% of women aged 70 or more had this treatment option.
PLOS ONE | DOI:10.1371/journal.pone.0153704 May 5, 2016 1 / 11
a11111
OPEN ACCESS
Citation: Mennie JC, Mohanna P-N, O’Donoghue
JM, Rainsbury R, Cromwell DA (2016) The
Proportion of Women Who Have a Breast 4 Years
after Breast Cancer Surgery: A Population-Based
Cohort Study. PLoS ONE 11(5): e0153704.
doi:10.1371/journal.pone.0153704
Editor: Yoshiaki Taniyama, Osaka University
Graduate School of Medicine, JAPAN
Received: November 9, 2015
Accepted: April 3, 2016
Published: May 5, 2016
Copyright: © 2016 Mennie et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: The Hospital Episode
Statistics (HES) data for this study was supplied by a
third party and is subject to a Data Sharing
Agreement and copyright license. All interested
parties are able to obtain the HES dataset in the
same manner as our study, directly from the NHS
Health and Social Care Information Centre via
(enquiries@HSCIC.gov.uk). Researchers who wish to
use HES data need to make a formal application to
the NHS Health and Social Care Information Centre.
Funding: JCM was funded by a grant received from
the British Association of Plastic Reconstructive and
Conclusion
The proportion of women diagnosed with breast cancer who retain a breast at 4 years is
strongly associated with age, and presence of comorbidities. There was significant variation
between Cancer Networks indicating that women’s experience in England was dependent
on their geographical location of treatment.
Introduction
The psychosocial impact on women with breast cancer who undergo mastectomy has been
well documented. Loss of the breast has been associated with a negative impact on confidence,
emotional and sexual well-being, as well as satisfaction with appearance.[1] This effect is widely
recognised, and women have various potential options to retain a breast after treatment. For
women with early-stage breast cancer, evidence has shown no difference in survival benefit
between breast conserving therapy (BCS) with adjuvant Radiotherapy and mastectomy alone.
[2] In addition the development of breast cancer screening and earlier detection of breast can-
cer, alongside the developments in adjuvant therapies, have contributed to a rise in women
having this type of surgery.[3]
For women undergoing mastectomy, the National Institute for Health and Clinical Excel-
lence (NICE) has recommended that reconstruction should be available to all women since
2002.[4] However, despite this guidance, gross inequalities in access to oncoplastic reconstruc-
tion services were highlighted by the National Mastectomy and Breast Reconstruction Audit in
2008.[5,6] NICE subsequently published revised guidelines that reiterated the importance of
women being offered reconstruction, irrespective of whether the service is available locally.[7]
Whether a women’s specific treatment pathway results in conserving or reconstructing the
breast is dependent upon several factors: disease stage, tumour size, comorbidities, choice, and
not only service quality but service availability. The multidisciplinary approach to breast cancer
in the UK recognises that all such variables have to be considered, and that the selected path-
way is arrived at after an informed patient choice.
However, not all women achieve their initial treatment outcomes. For example, women hav-
ing BCS as their primary treatment may proceed to mastectomy if resection margins are
incomplete, and in women with mastectomy and reconstruction, the reconstruction may fail.
Previous studies examining breast cancer care pathways have been limited by short follow-up
that would have missed these pathway changes, or limited by reporting on only one type of sur-
gical outcome. [3,6,8]
With the multiple interconnected potential pathways, assessing the care women with breast
cancer receive is complex, [9] and we sought to describe the performance of breast cancer care
across England using a new approach. We determined the proportion of women who have a
breast, either through conserving surgery or reconstruction, 4-years from the date of initial
breast cancer surgery. We also examined whether the proportion was influenced by age or
comorbidities, and whether the proportion varied across the English Cancer Networks.
Methods
Patient selection
This study used data extracted from the Hospital Episode Statistics (HES) database between 1
January 2000 and 31 March 2014.[10] This database contains records on all patients admitted
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to English NHS hospitals, and allocates patients a unique identifier that allows for longitudinal
follow-up of individuals. Each record contains demographic and clinical information including
diagnoses, and operative procedures. Diagnoses are coded using International Classification of
Diseases, 10th revision (ICD10),[11] while procedures are coded using the UK Office for Popu-
lation Census and Surveys classification, 4th revision (OPCS4).[12]
The study included women aged 16 years or over with breast cancer (ICD10: C50 and D05)
who underwent initial mastectomy (OPCS4: B27) or BCS (OPCS4:B28 excluding B28.4)
between 1 January 2008 and 31 December 2009 in English NHS hospitals. Women undergoing
prophylactic surgery were excluded. Women with previous or subsequent contralateral BCS or
mastectomy were also excluded. We then identified all mastectomy, BCS, and breast recon-
struction procedures in NHS hospitals during the subsequent four years, as previous work had
shown most delayed reconstruction procedures were performed within this timeframe. We
included all types of reconstruction procedures: implants, expanders, pedicled flaps and free
flaps (codes available on request). Patient age was defined as age at initial breast cancer surgery.
The presence of comorbidities was based on a woman’s RCS Charlson comorbidity score,[13]
with the exception of a diagnosis of breast cancer (which was removed from the list of condi-
tions counted in the Charlson score) as all patients had this diagnosis code. Finally, each
woman was assigned to one of the 28 English Cancer Networks that existed on 31 March 2012
based on the hospital provider code at initial surgery.
Outcome definition
The proportion of women with a breast at 4 years was defined as the primary outcome measure
and was determined by the pattern of surgical procedures that they underwent. The propor-
tions of women with a breast at baseline and at intermediate times were regarded as intermedi-
ate outcomes. At baseline, women were assigned into one of three treatment categories based
on their initial cancer surgery: BCS, mastectomy alone, or mastectomy with immediate recon-
struction. Two further treatment categories were created for women who went on to have a
delayed reconstruction or who lost their reconstruction. Women were allocated to the appro-
priate treatment category at 1, 2, 3, and 4 years after initial surgery based on their initial cate-
gory and type of breast procedure they had undergone during the subsequent years (if any).
The proportion of women with a breast at each time point included only those women with
BCS or an intact reconstruction after mastectomy. Women who had undergone mastectomy
alone or who had suffered a loss of reconstruction were labelled as not having retained a breast.
Analysis
The proportions of women in the five treatment categories were calculated at baseline and the
annual follow-up time points for the overall cohort and for four patient groups whose definition
reflected factors known to influence treatment pathways. The four groups were: women aged less
than 70 years without comorbidities (Group 1) or with comorbidities (Group 2), and women
aged 70 years or older without comorbidities (Group 3) or with comorbidities (Group 4).
We then examined differences in the primary outcome (the proportion of women with a
breast at 4 years) among regional Cancer Networks within each patient group. To describe the
degree of systematic variation in the distribution of Network proportions (ie, the amount of
variation above that expected from random fluctuations), we calculated the additive overdis-
persion statistic using the method of moments approach.[14] The Pearson correlation coeffi-
cient was derived to examine the variation among the Cancer Network variation across patient
groups. Finally, we examined the contribution of BCS and reconstruction procedures to the
proportion of women with a breast at 4 years in the individual Cancer Networks among
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women aged less than 70 years without comorbidities (Group 1). The statistical significance of
differences in the use of BCS and reconstruction was assessed with the chi-squared test. All sta-
tistical tests were two-sided with p-values less than 0.05 indicating a significant result. The
analyses were performed using STATA version 13.1.
We identified patients who died in hospital during the 4 year follow-up and investigated
how removing these patients from our cohort after their death changed the results. Their
removal produced only minimal differences and consequently, for simplicity, these patients
were not excluded from the results presented.
Ethics Statement
The study was exempt from UK NREC approval because it involved the analysis of an existing
dataset of anonymous data for service evaluation. Approvals for the use of HES data were
obtained as part of the standard Hospitals Episode Statistics approval process.
Results
Between January 2008 and December 2009, a total of 60,959 women with breast cancer under-
went primary BCS or mastectomy procedures in English NHS trusts. Women were mostly less
than 70 years, of white ethnicity, with no comorbidities, and had a diagnosis of invasive disease
(S1 Appendix). The majority of women (n = 39,193; 64.3%) underwent initial BCS (Table 1).
Out of the 21,766 women having a mastectomy, 3084 (14.2%) received an immediate
reconstruction.
After 4 years, the number of women still categorised as BCS had dropped from 64.3% to
57.6%. The drop occurred predominantly in the first year of follow-up, with 3,587 women pro-
ceeding to mastectomy (with or without reconstruction). Of these women, 82.7% underwent a
mastectomy within 90 days. The proportion of women in the “mastectomy alone” category
changed in each year, reflecting both the number of mastectomies after BCS and women hav-
ing delayed reconstruction. At 4 years, a total of 6284 women had undergone reconstruction
(immediate or delayed) after mastectomy, which represents 24.6% of all women who had mas-
tectomy, and 10.3% of the total cohort. We identified 439 women whose reconstruction after
mastectomy had failed and who had not undergone further reconstruction at 4 years follow-
up. Overall, the proportion of women with a breast 4 years after initial breast cancer surgery
was 67.9%.
There were distinct differences between the four patient groups in the proportion of women
with a breast at 4 years (Fig 1). In women aged less than 70 years without comorbidities
(Group 1), 79.3% of women retained a breast at 4 years. In women of the same age but with
comorbidities (Group 2), 64% of women had a breast 4 years. Among women aged 70 years
Table 1. Number and proportion of womenwith BCS, Mastectomy, Mastectomy with reconstruction and loss of reconstruction at initial surgery
and yearly for 4 years.
Type of surgery Number of women at initial
surgery
Initial surgery
(%)
At 1 year
(%)
At 2 years
(%)
At 3 years
(%)
At 4 years
(%)
BCS 39,193 64.3 58.4 58.2 57.9 57.6
Mastectomy alone 18,682 30.6 34.4 32.7 31.6 31.4
Mastectomy with
Reconstruction
3,084 5.1 6.8 8.5 9.8 10.3
Loss of Reconstruction n/a n/a 0.4 0.6 0.7 0.7
doi:10.1371/journal.pone.0153704.t001
Rates of Breast Retention after Breast Cancer Surgery
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and over, the proportion of women with a breast at 4 years was 52.6% and 38.2%, respectively,
when comorbidities were not present / present.
This difference between the groups was predominantly related to a difference in BCS pro-
portions rather than to the use of reconstruction. For example, in Group 1, 65.9% of women
maintained a breast through BCS, whereas for women in Group 2, this proportion was only
50.9%. Few women aged 70 years and over underwent reconstruction.
Whilst the overall proportion of women with a reconstructed breast in Groups 1 and 2 did
not differ, there were differences in the ratio of immediate to delayed reconstructions. Of the
women with a reconstructed breast in Group 1, 63.8% had immediate reconstruction, and
36.2% delayed reconstruction. In Group 2, the proportions were 47.9% (immediate) and 52.1%
(delayed).
There was substantial variation across Cancer Networks in the proportion of women with a
breast at 4 years within each patient group (Fig 2). There was at least at 15% absolute difference
between the highest and lowest Network values within each group, with the least variation
being observed in the younger, most fit women (Group 1). The greatest Network-level varia-
tion was found among women aged 70 years or older with comorbidities (Group 4). In this
group of women, the proportion of women with a breast ranged from 28.6% to 52.9%.
The scatter plots in Fig 3 reveal that Networks with a high proportion of women with a
breast after 4-years in one group tended to have high values across the other patient groups.
There were some exceptions (S2 Appendix). One Network had a relatively low proportion of
women with a breast for Group 1, but a relatively high proportion of women with a breast
across Groups 2–4. Another Cancer Network had one of the highest proportions of women
with a breast in Group 1, but as comorbidities and age increased, their values dropped to
become one of the lowest amongst all Cancer Networks.
We examined the ratio of BCS and reconstruction procedures among patients in which it
was expected that there would be the most uniform pattern of care: women aged less than 70
years without comorbidities (Group 1). There were significant differences in the ratio of BCS
to reconstruction across the Networks (chi-squared test = 207.7, p<0.001), and there did not
Fig 1. Proportion of womenwith BCS, MxIR, MxDR, Loss of Reconstruction, and Mastectomy at 1 year
intervals after initial surgery in each patient group.MxIR: Mastectomy with immediate reconstruction.
MxDR: Mastectomy with delayed reconstruction.
doi:10.1371/journal.pone.0153704.g001
Rates of Breast Retention after Breast Cancer Surgery
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seem to be a typical ratio of BCS to reconstruction (Fig 4). For example, Cancer Networks N24
and N34 had a similar proportion of women with a breast at 4-years but Network N34 achieved
this with a relatively high proportion of BCS (and the lowest reconstruction rate at 9.2%) while
Network N24 had the highest proportion of reconstructions at 21% and a relatively low pro-
portion of women with BCS. (S3 Appendix)
Fig 3. Correlation matrix showing correlation between the proportions of womenwith a breast in each
patient group across the Cancer Networks. The x-axis represents the group at the top of the plot, and the
y-axis the group on the right. The linear association between patient groups is described by the correlation
coefficients.
doi:10.1371/journal.pone.0153704.g003
Fig 2. Distribution across Cancer Networks in the proportion of womenwith a breast 4 years after
initial cancer surgery for each patient group. The bottom and top of the box show the 25th and 75th
percentiles, and the bottom and top lines show the minimum and maximum values, respectively. The degree
of systematic variation within each group is described using an additive overdispersion statistic, tau, the
square root of the between-Network variance.
doi:10.1371/journal.pone.0153704.g002
Rates of Breast Retention after Breast Cancer Surgery
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Discussion
Many studies use the rate of breast conserving surgery among women with breast cancer or the
rate of reconstruction after mastectomy as measures of performance for breast cancer units.
However, these measures fail to capture the complexity of the treatment pathway and so lead
to only a partial understanding of practice. In this study, we have adopted the proportion of
women with a breast at 4 years after their initial surgery as an alternative, more comprehensive
measure. The measure includes breast conserving, mastectomy, and reconstruction procedures
and thus provides a more reliable picture of clinical practice. It is appreciated that due to intri-
cacies such as touch and feel that BCS is not equivalent to reconstruction. However both BCS
and Reconstruction procedures result in a better quality of life and patient reported breast sat-
isfaction comparative to mastectomy alone.[15,16]
Overall, we found that 67.9% of 60,959 women undergoing initial breast cancer surgery in
English NHS hospitals had a breast after 4 years. But grouping women according to their age
and the presence of comorbid conditions revealed important differences between patients. The
proportion of women with a breast after 4 years was highest (79.3%) among women aged less
than 70 years without comorbidities. For comorbid women in the same age band, the propor-
tion had dropped to 64.0%. Among women aged 70 years or older, the proportion was 52.6%,
and 38.2%, respectively for women with and without comorbidities. The proportions varied
substantially among the 28 Cancer Networks within each of the patient groups, with this varia-
tion being most significant for comorbid women aged 70 years or older. In addition, we found
that Cancer Networks tended to have a high / low proportion consistently across all four
patient groups. Although these Networks no longer exist, they still represent an informative
level of aggregation as the provision of breast conserving, mastectomy, and reconstruction pro-
cedures are interconnected within English regions.
Strengths and limitations
The study has several strengths. First, it used a comprehensive national database that included
all women undergoing initial breast cancer surgery over a 2-year period in English NHS hospi-
tals, which reduced the risk of selection bias and yielded a large study cohort. Second, the
Fig 4. Variation across Cancer Networks of the proportion of womenwith a breast 4 years after initial
cancer surgery through BCS and Reconstruction in patient group 1.
doi:10.1371/journal.pone.0153704.g004
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follow-up period for each patient was 4 years, which exceeded the mean time to delayed recon-
struction reported in literature, and allowed pathway changes to be identified. [17,18]
The study has a number of limitations. The coding of diagnoses and procedures in an admin-
istrative hospital database may suffer from errors or omissions. Studies examining the coding of
breast cancer surgery within HES, however, concluded that the coding of these procedures is
accurate, finding 90–93% agreement with data provided by surgeons in England.[19]Moreover,
there are specific codes for breast conserving surgery and mastectomy, which should reduce the
risk of mis-classifying operations. We used a wide range of procedure codes to identify recon-
struction and loss of reconstruction in order to minimise the effect of different coding patterns
within hospitals. Consequently, bias due to errors in procedure coding is likely to be small.
Another limitation of HES is that it does not contain information on tumour size, disease
stage, or patient preference. The decision for BCS versus mastectomy, and the proportion of
women with a conserved breast, will be influenced by these variables. The National Cancer
Intelligence Network has reported only modest variation in breast cancer incidence between
regions.[20] Further, two separate studies have shown non-significant variation in breast can-
cer stage at presentation across Cancer Network regions.[21,22] Adjusting for tumour size or
disease stage would therefore be unlikely to significantly reduce the between-Network variation
that was observed.
HES also does not contain information on whether the cancer was screen-detected or symp-
tomatic. During the study time period (January 2008 to December 2009), routine breast cancer
screening was offered to women aged 50–70 years with an uptake of 77%.[23] A review of prac-
tice in the UK found significantly higher BCS rates in women with screen-detected cancers
(73%) versus symptomatic cancers (47%), which may explain the influence of age on BCS pro-
portions.[24] Nonetheless, differences in the presentation route between women aged less than
and greater than 70 years would not account for the significant variation observed in the use of
reconstruction.
Clinical implications
The findings of this study highlight two issues that influence the proportion of women having
surgery for breast cancer who retain a breast at 4-years. The first is whether the initial surgery
undergone was BCS or mastectomy, despite the option of immediate or delayed reconstruction.
The second is the influence of increasing age and the presence of comorbidities on the type of
surgery undergone.
Increasing age and the presence of comorbidities might be expected to lower the ratio of
BCS to mastectomy for various reasons.[9] For instance, whilst survival following BCS with
radiotherapy has been shown comparable to mastectomy, a woman may require further sur-
gery after BCS due to compromised margins.[2] In comorbid women, the higher proportion of
mastectomies may reflect a perceived benefit of having one operation and an attempt to avoid
further anaesthetic risk or radiotherapy. However Eaker et al found large differences across the
whole pathway of care in older women, and concluded that it would be difficult to explain by
comorbidities alone.[8] It should not be assumed that the overall proportion of women with a
breast at 4 years within Groups 2–4 cannot be increased. It has been shown that women from
deprived areas, who are more likely to have comorbidities, are less likely to attend for screen-
ing.[25] Current differences in the presentation route amongst comorbid women may there-
fore impact on a woman’s suitability for BCS, and these could be amenable to targeted
improvement initiatives.[8,9]
Another area for further exploration is the influence of comorbidity on the ratio of immedi-
ate to delayed reconstruction. Oncoplastic breast reconstruction guidelines recommend
Rates of Breast Retention after Breast Cancer Surgery
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reconstruction should be offered to all women expected to have a mastectomy, except where
comorbidities preclude it.[26] The results of this study are broadly consistent with this recom-
mendation among women aged less than 70 years, with 63.8% of reconstructions being imme-
diate in women without comorbidities compared with 47.9% in women with comorbidities.
However, there may be further potential to increase the proportion of women retaining a breast
with greater use of delayed reconstruction.
Our study again highlights low rates of reconstruction among women aged over 70 years,
even without precluding comorbidities, something that was reported in a review of UK practice
in 2007.[24] One explanation for this finding is that advanced tumours that require adjuvant
therapy are more common among older women and, as such, a lower percentage of these
women will be suitable for immediate reconstruction;[27] oncoplastic guidelines recognise the
decision for immediate reconstruction should be made in consideration for potential adjuvant
therapy.[26] However, the 4-year follow-up of our study allows sufficient time for women
potentially requiring adjuvant therapy to undergo delayed reconstruction and so it seems
unlikely that this explanation accounts for these findings. More plausible explanations for the
low rate of reconstruction in older women are patient preferences and/or restrictions on
access.[28]
That there is potential to increase the proportion of women retaining a breast is best dem-
onstrated by the variation we observed across Cancer Networks, and in particular that Net-
works seemed to perform consistently so across all four patient groups. This suggests that the
structure and process by which care is delivered in these Networks play an important role in
determining the specific pathway followed by women, and both require investigation.[29]
Moreover, while the variation across Cancer Networks was greatly influenced by the propor-
tion of women receiving BCS, there was not a uniform picture across the networks in terms of
the use of BCS and reconstruction. Among Networks with a high proportion of women having
BCS, there were Networks with both high and low proportions of women having mastectomy
with reconstruction. This reiterates the importance of reporting BCS, mastectomy, and recon-
struction together when investigating the provision of breast cancer services.
Conclusion
In this study, we used the proportion of women with a breast at 4 years after their initial sur-
gery as comprehensive measure of breast cancer surgery to describe the complex outcomes of
breast cancer surgery in a simple way and which provides useful information for patients and
health services. Overall, we found that two-thirds of women undergoing breast cancer surgery
in English NHS hospitals retain a breast after 4 years. However, this proportion was strongly
influenced by age and comorbidities, with the proportions in our four patient groups being
79.3%, 64.0%, 52.6%, and 38.2%. In addition, we found significant variation across Cancer Net-
works in all four patient groups. This is of concern as it indicates that women’s experience and
standard of care is dependent on their geographical location of treatment. These results should
encourage breast cancer services to review their performance with the aims of both reducing
the regional variation and increasing access to BCS and post-mastectomy reconstruction.
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